Nasal ObstructionNCT01457638
Inferior Turbinate Surgery in Rhinoseptoplasty: a Randomized Clinical Trial With Quality of Life Outcomes
A study testing Inferior turbinate surgery and No iInferior turbinate surgery in people with Nasal Obstruction and Rhinoplasty, run by Hospital de Clinicas de Porto Alegre at 1 site in Brazil.
Trial summary
The purpose of this study is to determine whether inferior turbinate surgery during rhinoseptoplasty is effective in improving quality of life and acoustic rhinometry outcomes. Read more about this study
- Who is it for?
- Ages 16 years and olderHealthy volunteers can take part
- Conditions the study is for
- Nasal Obstruction, Rhinoplasty, Rhinoseptoplasty
- What is being tested?
- Inferior turbinate surgery and No iInferior turbinate surgery
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 50 participants
- Where
- 1 siteBrazil
- Study dates
- Dec 2010to Oct 2011
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 16 years and older
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- Older than 15 years old;
- Nasal obstruction and nasal aesthetics complaints;
Who cannot join
- Previous septoplasty, turbinates intervention and/or rhinoplasty;
- Association of other surgical procedures in the same surgical time, as functional endoscopic sinus surgery, blepharoplasty, mentoplasty or otoplasty;
- Inferior turbinate hypertrophy as the isolated cause of nasal obstruction (no septum deviation or internal valve collapse)
Trial locations and contacts
1 site in 1 country.
Brazil1 site
Hospital de Clínicas de Porto Alegre
Porto Alegre, Rio Grande do Sul
About this study
Official title: Inferior Turbinate Surgery in Rhinoseptoplasty: a Randomized Clinical Trial With Quality of Life and Acoustic Rhinometry Outcomes
The purpose of this study is to determine whether inferior turbinate surgery during rhinoseptoplasty is effective in improving quality of life and acoustic rhinometry outcomes.
- Being tested
- Inferior turbinate surgery, No iInferior turbinate surgery
- Keywords
- nasal obstruction, rhinoplasty, turbinate surgery, quality of life, acoustic rhinometry
- Medical subject headings
- Nasal Obstruction
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Inferior turbinate surgeryProcedure or surgery
During rhinoseptoplasty inferior turbinate submucosal cauterization is performed.
No iInferior turbinate surgeryProcedure or surgery
During rhinoseptoplasty no intervention is done in inferior turbinates
| Study group | Role | What they receive |
|---|---|---|
| No inferior turbinate surgery | Sham comparator | During rhinoseptoplasty there is no intervention on inferior turbinates Receives: Procedure: No iInferior turbinate surgery |
| Inferior Turbinate surgery | Experimental | During rhinoseptoplasty, inferior turbinate submucosal cauterization is performed. Receives: Procedure: Inferior turbinate surgery |
What is being measured
The primary outcome is the main question the study is designed to answer.
Nasal Obstructive Symptoms Evaluation Scale
Specif instrument for evaluation of quality of life related to nasal obstruction
Measured: 3 months postop
Secondary outcomes (9)
Acoustic Rhinometry
Measured: 3 months post-op
World Health Organization Quality of Life (WHOQOL)
quality of life instrument
Measured: 3 months postop
Rhinoplasty Outcomes Evaluation
quality of life for rhinoplasty patients
Measured: 3 months postop
Allergic Conjunctivitis
At 90 posoperative day patients were asked if they had allergic conjunctivitis for more than one hour a day on most days, or not.
Measured: 3 months postop
Nasal Rhinorrea
At 90 posoperative day patients were asked if they had nasal rhinorrea for more than one hour a day on most days, or not.
Measured: 3 months postop
Nasal pruritis
At 90 posoperative day patients were asked if they had nasal pruritis for more than one hour a day on most days, or not.
Measured: 3 months posopt
Nasal Sneeze
At 90 posoperative day patients were asked if they had nasal sneeze for more than one hour a day on most days, or not.
Measured: 3 months postop
Topic nasal corticosteroid
At 90 posoperative day patients were asked if they were using topic nasal corticosteroid or not.
Measured: 3 months
Oral antihistamine
At 90 posoperative day patients were asked if they had used oral antihistamine in the past 30 days or not
Measured: 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Oct 2011 (estimated)
- Study startDec 2010
- Primary completionOct 2011
- Study completionOct 2011
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Nasal ObstructionStudies of the same condition, open and under way.
- More trials run by Hospital de Clinicas de Porto AlegreThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 50 participants (actual)
Sponsor and investigators
- Lead sponsor
- Hospital de Clinicas de Porto Alegre
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Michelle L Wolff, Principal investigator, Hospital de Clinicas de Porto Alegre/ Universidade Federal do Rio Grande do SulCarisi A Polanczyck, PhD, Study chair, Federal University of Rio Grande do SulJosé E Dolci, PhD, Study chair, Faculdade de Ciências Médicas da Santa Casa de São Paulo
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01457638
- Sponsor's protocol ID
- 1004-20
- Status last verified
- Jan 2019
- First submitted
- 17 Oct 2011
- Last updated
- 17 Jan 2019
- Results posted
- No
- Data monitoring committee
- No
Publications
Garcia JPT, Moura BH, Rodrigues VH, Vivan MA, Azevedo SM, Dolci JEL, Migliavacca R, Lavinsky-Wolff M. Inferior Turbinate Reduction during Rhinoplasty: Is There Any Effect on Rhinitis Symptoms? Int Arch Otorhinolaryngol. 2021 Aug 5;26(1):e111-e118. doi: 10.1055/s-0041-1726046. eCollection 2022 Jan.
PubMed 35096167Lavinsky-Wolff M, Camargo HL Jr, Barone CR, Rabaioli L, Wolff FH, Dolci JE, Polanczyk CA. Effect of turbinate surgery in rhinoseptoplasty on quality-of-life and acoustic rhinometry outcomes: a randomized clinical trial. Laryngoscope. 2013 Jan;123(1):82-9. doi: 10.1002/lary.23628. Epub 2012 Oct 15.
PubMed 23070968
Study at a glance
From the registry record, last updated by the sponsor on 17 Jan 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Inferior Turbinate Surgery in Rhinoseptoplasty: a Randomized Clinical Trial With Quality of Life and Acoustic Rhinometry Outcomes
- ClinicalTrials.gov ID
- NCT01457638
- Acronym / sponsor ID
- 1004-20
- Keywords
- nasal obstruction, rhinoplasty, turbinate surgery, quality of life, acoustic rhinometry
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 50 participants (actual)
- Lead sponsor
- Hospital de Clinicas de Porto AlegreUniversity, hospital or other
- Study start
- Dec 2010 (actual)
- Primary completion
- Oct 2011 (actual)
- Study completion
- Oct 2011 (actual)
- First posted
- 24 Oct 2011 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to determine whether inferior turbinate surgery during rhinoseptoplasty is effective in improving quality of life and acoustic rhinometry outcomes.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| No inferior turbinate surgery | Sham comparator | Procedure: No iInferior turbinate surgeryDuring rhinoseptoplasty there is no intervention on inferior turbinates |
| Inferior Turbinate surgery | Experimental | Procedure: Inferior turbinate surgeryDuring rhinoseptoplasty, inferior turbinate submucosal cauterization is performed. |
Who may qualify
- Ages
- 16 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (2 listed)
- Older than 15 years old;
- Nasal obstruction and nasal aesthetics complaints;
Key exclusion criteria (3 listed)
- Previous septoplasty, turbinates intervention and/or rhinoplasty;
- Association of other surgical procedures in the same surgical time, as functional endoscopic sinus surgery, blepharoplasty, mentoplasty or otoplasty;
- Inferior turbinate hypertrophy as the isolated cause of nasal obstruction (no septum deviation or internal valve collapse)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Inferior turbinate surgeryDuring rhinoseptoplasty inferior turbinate submucosal cauterization is performed. | Procedure or surgery | Inferior Turbinate surgery |
| No iInferior turbinate surgeryDuring rhinoseptoplasty no intervention is done in inferior turbinates | Procedure or surgery | No inferior turbinate surgery |
Primary outcome
Nasal Obstructive Symptoms Evaluation Scale
Time frame: 3 months postop
Specif instrument for evaluation of quality of life related to nasal obstruction
9 secondary outcomes
Acoustic Rhinometry
Time frame: 3 months post-op
World Health Organization Quality of Life (WHOQOL)
Time frame: 3 months postop
Rhinoplasty Outcomes Evaluation
Time frame: 3 months postop
Allergic Conjunctivitis
Time frame: 3 months postop
Nasal Rhinorrea
Time frame: 3 months postop
Nasal pruritis
Time frame: 3 months posopt
Nasal Sneeze
Time frame: 3 months postop
Topic nasal corticosteroid
Time frame: 3 months
Oral antihistamine
Time frame: 3 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Jan 2019.
- Derived from this study: PubMed 35096167Garcia JPT, Moura BH, Rodrigues VH, Vivan MA, Azevedo SM, Dolci JEL, Migliavacca R, Lavinsky-Wolff M. Inferior Turbinate Reduction during Rhinoplasty: Is There Any Effect on Rhinitis Symptoms? Int Arch Otorhinolaryngol. 2021 Aug 5;26(1):e111-e118. doi: 10.1055/s-0041-1726046. eCollection 2022 Jan.
- Derived from this study: PubMed 23070968Lavinsky-Wolff M, Camargo HL Jr, Barone CR, Rabaioli L, Wolff FH, Dolci JE, Polanczyk CA. Effect of turbinate surgery in rhinoseptoplasty on quality-of-life and acoustic rhinometry outcomes: a randomized clinical trial. Laryngoscope. 2013 Jan;123(1):82-9. doi: 10.1002/lary.23628. Epub 2012 Oct 15.
Related trials for Nasal Obstruction
Not yet recruiting
Influence of Patient Positioning During Nasal Lavage
Acute Upper Respiratory Tract Infections, Nasal Obstruction
Recruiting
Pharyngeal Mucosal Conditioning to Prevent Postoperative Sore Throat in Septoplasty Patients With Severe Nasal Obstruction
Postoperative Sore Throat, Nasal Obstruction
Active, not recruitingObservational study
A Prospective Study Comparing VivAer to Alternative Surgical Procedures to Treat Nasal Airway Obstruction in Patients With Nasal Valve Dysfunction.
Nasal Airway Obstruction
Recruiting
Measuring Nasal Airway Changes After VivAer Treatment Using AI Analysis
Nasal Airway Obstruction
Recruiting
Post-Market Clinical Study to Evaluate the Safety and Effectiveness of REFLEX ULTRA 45 for Coblation Inferior Turbinate Reduction in China
Nasal Obstruction Due to Inferior Turbinate Hypertrophy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Michelle L Wolff principal investigator
Hospital de Clinicas de Porto Alegre/ Universidade Federal do Rio Grande do Sul
Carisi A Polanczyck, PhD study chair
Federal University of Rio Grande do Sul
José E Dolci, PhD study chair
Faculdade de Ciências Médicas da Santa Casa de São Paulo
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Inferior turbinate surgery and No iInferior turbinate surgery in people with Nasal Obstruction and Rhinoplasty, run by Hospital de Clinicas de Porto Alegre at 1 site in Brazil.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 17 Jan 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Nasal Obstructive Symptoms Evaluation Scale (time frame: 3 months postop). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01457638, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jan 2019.